The increased insoluble TMEM106B led us to examine the consequence of reducing TMEM106B in the inflammatory model of experimental autoimmune encephalomyelitis (EAE) [27], and the cuprizone model [28], to determine if decreased TMEM106B in a hypomorphic mouse impacts the clearance of lipids. This evidence concerns the gene TMEM106B and experimental autoimmune encephalomyelitis.